Results 91 to 100 of about 838,554 (221)
Introduction: Carbapenem-resistant Acinetobacter baumannii poses significant challenges in clinical settings due to rapid emergence and limited treatment options.
Ruixiang Luo +8 more
doaj +1 more source
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections. [PDF]
Carbapenem-resistant Acinetobacter baumannii has been associated with over three hundred thousand annual deaths globally. It is resistant to most available antibiotics and associated with high morbidity and mortality. No global consensus currently exists for treatment strategies that balance safety and efficacy because of heterogeneity of treatment ...
Iovleva A, Fowler VG, Doi Y.
europepmc +3 more sources
Bachground and Aim: Acinetobacter baumannii is one of the important caues of nosocomial infection. Resistance to antibiotics specially carbapenem antibiotics is on the increase which can be an alarming sign for healthcare managers and personnel.
Mohsen Moghadasi +5 more
doaj
Carbapenem Resistance in Acinetobacter baumannii: Mechanisms, Therapeutics, and Innovations
The global rise of carbapenem-resistant Acinetobacter baumannii (CRAB) strains poses a critical challenge to healthcare systems due to limited therapeutic options and high mortality rates, especially in intensive care settings. This review explores the epidemiological landscape and molecular mechanisms driving carbapenem resistance, including the ...
Joyce de Souza +5 more
openaire +3 more sources
Risk factors and outcome in patients who acquire nosocomial infections due to carbapenem-resistant Acinetobacter baumannii (CRAB) are rarely investigated.
SHENG, WANG-HUEI;LIAO, CHUN-HSIN;YANG, LAUDERDALE TSAI-LING;KO, WEN-CHIEN;CHEN, YAO-SHEN;LIU, JIEN-WEI;LAU, YEU-JUN;LIU, KE-SUN;HSU, MENG- SHIUAN;CHANG, SHAN-CHWEN +1 more
core +1 more source
Repurposing a drug to punish carbapenem-resistant Acinetobacter baumannii
The OXA β-lactamases in Acinetobacter baumannii represent a primary mechanism for resistance to the carbapenems, a class of antibiotics that represent a last line for treatment. In a screen of an U.S. Food and Drug Administration (FDA)-approved drug library, we identified fendiline, a calcium
Jennifer M. Colquhoun +10 more
openaire +2 more sources
Abstract Carbapenem resistant Acinetobacter baumannii has evolved as the most troublesome microorganism with multiple virulence factors. Biofilm formation, porins, micronutrient capturing mechanism and quorum sensing, provide protection against ...
Swati Sharma +6 more
doaj +1 more source
Introduction: Carbapenem-resistant Acinetobacter baumannii (CRAB) infection is being increasingly observed and is associated with significant morbidity and mortality in newborns.
Ajay Kumar +4 more
doaj +1 more source
Dissemination of carbapenem-resistant Acinetobacter baumannii in patients with burn injuries
Carbapenem-resistant Acinetobacter baumannii has emerged as an important cause of infection in burn patients. This study aimed to characterize the antimicrobial susceptibility pattern, determine the prevalence of oxacillinase and metallo-beta-lactamase (MBL) genes, and type the A. baumannii isolates obtained from burn patients.During a 1-year period, a
Shoja, Saeed +6 more
openaire +2 more sources
Genetic Relationship of Multi-Resistant Acinetobacter baumannii Isolates in Kingdom of Saudi Arabia
In the last two decades, there has been a remarkable rise in the instances of nosocomial infections associated with antibiotic-resistant Acinetobacter baumannii.
Reem Aljindan, Nasreldin Elhadi
core +1 more source

